等待開盤 01-29 09:30:00 美东时间
+1.240
+1.27%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-24 00:22
Piper Sandler analyst Stephen Scouten maintains Texas Capital Bancshares (NASDAQ:TCBI) with a Neutral and raises the price target from $86 to $96.
01-23 21:11
华盛资讯1月22日讯,德州资本银行公布2025财年Q4业绩,公司Q4营收3.27亿美元,同比增长15.4%,归母净利润0.96亿美元,同比增长44.4%。
01-22 20:32
Companies Reporting Before The Bell • Commerce Bancshares (NASDAQ:CBSH) is proj...
01-22 19:11
Texas Capital Bancshares (NASDAQ:TCBI) reported quarterly earnings of $2.08 per share which beat the analyst consensus estimate of $1.77 by 17.58 percent. This is a 45.45 percent increase over earnings of $1.43 per share
01-22 19:01
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
Raymond James analyst Michael Rose maintains Texas Capital Bancshares (NASDAQ:TCBI) with a Outperform and raises the price target from $98 to $105.
01-07 21:48
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46